ACADIA Pharmaceuticals Inc (ACAD)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 226,451 | 128,506 | 30,565 | -1,710 | -61,286 | -148,808 | -110,815 | -145,940 | -215,975 | -217,344 | -204,618 | -214,478 | -167,870 | -191,536 | -261,739 | -260,009 | -281,584 | -267,860 | -225,178 | -237,978 |
| Total assets | US$ in thousands | 1,187,760 | 976,868 | 914,099 | 855,103 | 748,956 | 632,540 | 642,769 | 655,305 | 587,812 | 602,491 | 612,766 | 624,251 | 700,122 | 717,673 | 724,429 | 755,173 | 782,616 | 795,664 | 759,649 | 747,450 |
| ROA | 19.07% | 13.15% | 3.34% | -0.20% | -8.18% | -23.53% | -17.24% | -22.27% | -36.74% | -36.07% | -33.39% | -34.36% | -23.98% | -26.69% | -36.13% | -34.43% | -35.98% | -33.66% | -29.64% | -31.84% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $226,451K ÷ $1,187,760K
= 19.07%
ACADIA Pharmaceuticals Inc's Return on Assets (ROA) experienced a declining trend from March 2020 to March 2024, starting at -31.84% and reaching a low of -36.74%. This downward movement indicates a decreasing ability of the company to generate profits relative to its total assets during this period.
However, from March 2024 onwards, the ROA showed a significant improvement, gradually turning positive. This suggests that the company's profitability in relation to its asset base has strengthened. Notably, the ROA increased from -0.20% in March 2024 to a positive 19.07% by December 2024, indicating a substantial enhancement in financial performance.
The positive ROA figures towards the end of the period may signal an improvement in the company's efficiency in utilizing its assets to generate earnings, potentially reflecting better operational management or strategic decisions. Overall, the positive turnaround in ROA from negative to positive values over the specified period suggests a positive shift in ACADIA Pharmaceuticals Inc's financial performance and asset utilization efficiency.
Peer comparison
Dec 31, 2024